Key Elements Affecting Biosimilar Uptake in the United States

Article
Conference|ASHP Midyear

Michael Ganio, PharmD, MS, BCPS, FASHP, ASHP Director of Pharmacy Practice and Quality, talks about biosimilar use and factors influencing uptake in the United States.

Michael Ganio, PharmD, MS, BCPS, FASHP, ASHP Director of Pharmacy Practice and Quality, talks about biosimilar use and factors influencing uptake in the United States.

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
Home Diabetes Treatment - Image credit: Dglimages | stock.adobe.com
Image credit: Azee/peopleimages.com | stock.adobe.com
Cropped view of senior man playing with puzzles on table- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Breast cancer with lymphatics, medically 3D illustration | Image Credit: Axel Kock - stock.adobe.com
Woman with pink ribbon on color background. Breast cancer awareness concept | Image Credit: Pixel-Shot - stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store- Image credit: C Daniels/peopleimages.com | stock.adobe.com
View in microscopic of pathology cross section tissue ductal cell carcinoma or adenocarcinoma diagnosis by pathologist in laboratory | Image Credit: arcyto - stock.adobe.com
A female doctor sits at her desk and talks to a female patient while looking at her mammogram | Image Credit: lordn - stock.adobe.com
Related Content
Assessing Clinical Trial Efficacy Vs Real-World Effectiveness in the Treatment of Multiple Myeloma

Assessing Clinical Trial Efficacy Vs Real-World Effectiveness in the Treatment of Multiple Myeloma

December 10th 2023
Article
Independent Rx Forum - NCPA Conference: Legal Update on PBM Litigation

Independent Rx Forum - NCPA Conference: Legal Update on PBM Litigation

October 24th 2023
Podcast
Women with cancer receiving treatment

No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens

December 8th 2023
Article
Independent Rx Forum - NCPA Conference: Seasonal Immunizations

Independent Rx Forum - NCPA Conference: Seasonal Immunizations

October 16th 2023
Podcast
The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects

The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects

December 8th 2023
Article
Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer

Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer

December 7th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.